Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 1 from Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
  1. Home
  2. Publications
  3. Supplementary Table 1 from Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma

Supplementary Table 1 from Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma

Authors:
  • ELEudocia Q. Lee
    Eudocia Q. Lee
  • BABrian M. Alexander
    Brian M. Alexander
  • CRCarlos G. Romo
    Carlos G. Romo
  • JSJeffrey G. Supko
    Jeffrey G. Supko
  • NANathalie Y.R. Agar
    Nathalie Y.R. Agar
  • ZTZahra Talebi
    Zahra Talebi
  • MAManmeet S. Ahluwalia
    Manmeet S. Ahluwalia
  • ADArati S. Desai
    Arati S. Desai
  • JDJorg Dietrich
    Jorg Dietrich
  • TKThomas J. Kaley
    Thomas J. Kaley
  • DPDavid M. Peereboom
    David M. Peereboom
  • JGJennifer Gantchev
    Jennifer Gantchev

Open Access
Publisher website
Google Scholar
  • 17 March 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.28606513
Abstract
Supplementary Table 1. Representativeness of Study Participants.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • CNS CANCERS
  • GLIOMAS, GLIOBLASTOMAS
  • PHARMACOLOGY
  • PHARMACOKINETICS AND PHARMACODYNAMICS
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.